Pregabalin Chew Treat
Pregabalin is a compounded formulation containing Pregabalin, prepared by Mixlab for veterinary use. Available by prescription.
Chew treats are flavored, soft treats that contain your pet’s medication—making giving meds as easy as offering a snack!
Use as directed by your veterinarian.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider pregabalin for patients experiencing chronic neuropathic pain or as an "add-on" medication for managing seizure activity when other protocols require additional support. It is frequently a point of discussion for pain management in cases of spinal cord injury, fibrocartilaginous embolism (FCE) or chronic arthritis where standard anti-inflammatory medications are not sufficient. By modulating the way the nervous system processes electrical signals, your veterinarian can help stop pain and manage the physiological "wind-up" associated with long-term nerve sensitivity.
At a pharmacological level, pregabalin acts by binding to the alpha-2-delta subunit of voltage-gated calcium channels within the central nervous system. This binding is understood to modulate calcium influx into nerve terminals, which in turn inhibits the release of excitatory neurotransmitters such as glutamate, norepinephrine and substance P. By dampening these signals, the medication helps stabilize overactive nerve cells without interfering with normal nerve communication. Your veterinarian will determine if pregabalin is appropriate based on your pet’s weight, health history and previous response to other neurological health protocols.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of pregabalin administration include sedation, lethargy and loss of coordination (ataxia). These signs are often most noticeable when the medication is first started and may decrease as your pet’s body adjusts. Some pets may also experience a temporary increase in appetite or mild gastrointestinal changes like vomiting. Owners should watch for significant weakness in the hind limbs or excessive sleepiness and contact their veterinarian promptly if these behavioral shifts occur.
This medication is typically used with extra caution or avoided in patients with known renal impairment, as pregabalin is primarily excreted by the kidneys. Because it is a controlled substance, it is essential to follow your veterinarian's guidance strictly and never abruptly stop the medication, which could lead to "rebound" seizure activity or increased sensitivity. Before starting a protocol, ensure your veterinarian has a complete history of all other prescriptions and supplements your pet is receiving, especially other sedatives or pain medications. Your veterinarian is the right person to design a comprehensive monitoring plan and provide guidance on the necessary duration of use to ensure the approach remains suitable for your pet's individual health status.
Yes. Pregabalin is a prescription medication and a Schedule V controlled substance. It can only be dispensed by a licensed pharmacy upon receipt of a valid authorization from a licensed veterinarian. Mixlab follows all state and federal guidelines regarding the dispensing of controlled substances.
Yes. While pregabalin is available in commercial capsule and oral solution formats, Mixlab can compound this medication into specialized strengths or flavored dosage forms—such as flavored oral liquids or chews—if your veterinarian determines a customized preparation better suits your pet's individual needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss pregabalin as a more potent structural relative of gabapentin with higher bioavailability and a longer duration of action in some species. While both medications act on the same calcium channel subunits, pregabalin may be considered when a pet requires a different metabolic profile or when a previous approach needs adjustment.
Sedation and lethargy are commonly observed effects when a pet first starts taking pregabalin. These effects are often transient as the body adjusts to the medication, and your veterinarian will determine the appropriate dose to balance neurological support with your pet's daily activity levels.
